English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  50712948    Online Users :  358
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"bai l y"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 41-50 of 50  (5 Page(s) Totally)
<< < 1 2 3 4 5 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-12-16T02:25:38Z Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer Kuo W.-H.; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Liu T.-P.; Lu Y.-S.; Bai L.-Y.; Sargeant A.M.; Lin C.-H.; Cheng A.-L.; Hsieh F.-J.; WUH-LIANG HWU; Chang K.-J.
臺大學術典藏 2020-05-25T06:51:59Z Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer Chang K.-J.;Hwu W.-L;Hsieh F.-J;Cheng A.-L;Lin C.-H;Sargeant A.M;Bai L.-Y;Yen-Shen Lu;Liu T.-P;Chien Y.-H;Huang A.-C;Lin P.-H;Kuo W.-H; Kuo W.-H; Lin P.-H; Huang A.-C; Chien Y.-H; Liu T.-P; YEN-SHEN LU; Bai L.-Y; Sargeant A.M; Lin C.-H; Cheng A.-L; Hsieh F.-J; Hwu W.-L; Chang K.-J.
臺大學術典藏 2020-03-24T04:02:54Z Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer Cheng A.-L.; Lin C.-H.; Sargeant A.M.; Lu Y.-S.; Bai L.-Y.; Liu T.-P.; WEN-HUNG KUO; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Hsieh F.-J.; Hwu W.-L.; Chang K.-J.
國立成功大學 2020 OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels Chiu, Chiu C.-F.;Weng, J.-R.;Lee, S.-L.;Wu, C.-Y.;Chu, P.-C.;Shan, Y.-S.;Yang, H.-R.;Bai, L.-Y.
國立成功大學 2020 A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data Chen, L.-T.;Satoh, T.;Ryu, M.-H.;Chao, Y.;Kato, Kato K.;Chung, H.C.;Chen, J.-S.;Muro, K.;Kang, W.K.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Sameshima, H.;Kang, Y.-K.;Boku, N.
國立成功大學 2020 Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer Satoh, T.;Kang, Y.-K.;Chao, Y.;Ryu, M.-H.;Kato, Kato K.;Cheol, Chung H.;Chen, J.-S.;Muro, K.;Ki, Kang W.;Yeh, K.-H.;Yoshikawa, T.;Oh, S.C.;Bai, L.-Y.;Tamura, Tamura T.;Lee, K.-W.;Hamamoto, Y.;Kim, J.G.;Chin, K.;Oh, D.-Y.;Minashi, K.;Cho, J.Y.;Tsuda, M.;Tanimoto, M.;Chen, L.-T.;Boku, N.
國立成功大學 2019 Effect of First-line S-1 Plus Oxaliplatin with or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial Yoshikawa, T.;Muro, K.;Shitara, K.;Oh, D.-Y.;Kang, Y.-K.;Chung, H.C.;Kudo, T.;Chin, K.;Kadowaki, S.;Hamamoto, Y.;Hironaka, S.;Yoshida, K.;Yen, C.-J.;Omuro, Y.;Bai, L.-Y.;Maeda, K.;Ozeki, A.;Yoshikawa, R.;Kitagawa, Y.
臺大學術典藏 2018-09-10T09:51:59Z Young nasopharyngeal cancer patients with radiotherapy and chemotherapy are most prone to ischaemic risk of stroke: A national database, controlled cohort study Chu, C.-N. ; Chen, P.-C. ; Bai, L.-Y. ; Muo, C.-H. ; Sung, F.-C. ; Chen, S.-W.; Pau-Chung CHEN
國立成功大學 2015-05-01 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Chen, J. S.; Hsu, C.; Chiang, N. J.; Tsai, C. S.; Tsou, H. H.; Huang, S. F.; Bai, L. Y.; Chang, I. C.; Shiah, H. S.; Ho, C. L.; Yen, C. J.; Lee, K. D.; Chiu, C. F.; Rau, K. M.; Yu, M. S.; Yang, Y.; Hsieh, R. K.; Chang, J. Y.; Shan, Y. S.; Chao, Y.; Chen, L. T.
臺大學術典藏 2015 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer on behalf of the Taiwan Cooperative Oncology Group; Wei T.-C.; Shan Y.S.; Chao Y.; Chen L.-T.; Chin Y.-H.; Chung T.-R.; Yu W.-L.; Lee M.-H.; Lin L.-F.; Lin P.-C.; Wu Y.-L.; Wang H.-L.; Lu L.-J.; Chen S.-Y.; Wu C.-C.; Chang J.Y.; Yu M.S.; Yang Y.; Hsieh R.K.; Chiu C.F.; Rau K.M.; Lee K.D.; Shiah H.S.; Chang I.C.; Bai L.Y.; Huang S.F.; Tsou H.H.; Tsai C.S.; Chiang N.J.; CHIH-HUNG HSU; Chen J.S.; Chen J.S.;Chih-Hung Hsu;Chiang N.J.;Tsai C.S.;Tsou H.H.;Huang S.F.;Bai L.Y.;Chang I.C.;Shiah H.S.;Ho C.L.;Yen C.J.;Lee K.D.;Chiu C.F.;Rau K.M.;Yu M.S.;Yang Y.;Hsieh R.K.;Chang J.Y.;Shan Y.S.;Chao Y.;Chen L.-T.;Chin Y.-H.;Chung T.-R.;Yu W.-L.;Lee M.-H.;Lin L.-F.;Lin P.-C.;Wu Y.-L.;Wang H.-L.;Lu L.-J.;Chen S.-Y.;Wu C.-C.;Wei T.-C.;On Behalf Of The Taiwan Cooperative Oncology Group; Yen C.J.; Ho C.L.

Showing items 41-50 of 50  (5 Page(s) Totally)
<< < 1 2 3 4 5 
View [10|25|50] records per page